Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastases.
van Nijnatten TJ, Simons JM, Moossdorff M, de Munck L, Lobbes MB, van der Pol CC, Koppert LB, Luiten EJ, Smidt ML. van Nijnatten TJ, et al. Among authors: moossdorff m. Breast Cancer Res Treat. 2017 May;163(1):159-166. doi: 10.1007/s10549-017-4157-0. Epub 2017 Feb 17. Breast Cancer Res Treat. 2017. PMID: 28213782 Free PMC article.
Diagnostic performance of gadofosveset-enhanced axillary MRI for nodal (re)staging in breast cancer patients: results of a validation study.
van Nijnatten TJA, Schipper RJ, Lobbes MBI, van Roozendaal LM, Vöö S, Moossdorff M, Paiman ML, de Vries B, Keymeulen KBMI, Wildberger JE, Smidt ML, Beets-Tan RGH. van Nijnatten TJA, et al. Among authors: moossdorff m. Clin Radiol. 2018 Feb;73(2):168-175. doi: 10.1016/j.crad.2017.09.005. Epub 2017 Oct 10. Clin Radiol. 2018. PMID: 29029766
A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer.
Schipper RJ, Moossdorff M, Nelemans PJ, Nieuwenhuijzen GA, de Vries B, Strobbe LJ, Roumen RM, van den Berkmortel F, Tjan-Heijnen VC, Beets-Tan RG, Lobbes MB, Smidt ML. Schipper RJ, et al. Among authors: moossdorff m. Clin Breast Cancer. 2014 Oct;14(5):315-22. doi: 10.1016/j.clbc.2013.12.015. Epub 2014 Jan 3. Clin Breast Cancer. 2014. PMID: 24548732
TNM classification and the need for revision of pN3a breast cancer.
van Nijnatten TJA, Moossdorff M, de Munck L, Goorts B, Vane MLG, Keymeulen KBMI, Beets-Tan RGH, Lobbes MBI, Smidt ML. van Nijnatten TJA, et al. Among authors: moossdorff m. Eur J Cancer. 2017 Jul;79:23-30. doi: 10.1016/j.ejca.2017.04.002. Eur J Cancer. 2017. PMID: 28458119
21 results